Dipeptidyl Peptidase IV (DPP IV) Inhibitors

Abstract

DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes mellitus in adults.